# Tiotropium + Olodaterol

## Spiolto Respimat 2.5/2.5mcg/puff

#### 一般可用

| 藥品代碼       | ESPOT                                                                                                                                                                                                                                                                                                                                                                                                        |
|:---------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | a long term maintenance treatment of patients with Chronic Obstructive Pulmonary Disease， including chronic bronchitis and emphysema.                                                                                                                                                                                                                                                                       |
| 用法用量       | Adults: The recommended dose is 5 mcg tiotropium and 5 mcg olodaterol (2 puffs) QD， at the same time of the day. SPIOLTOR RESPIMATR should not be used more frequently than once daily. Age < 18 years: Usually will not use.                                                                                                                                                                               |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                 |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                 |
| 禁忌           | Hypersensitivity to the active substances or to any of the excipients. History of hypersensitivity to atropine or its derivatives， e.g. ipratropium or oxitropium.                                                                                                                                                                                                                                          |
| 副作用         | Common Musculoskeletal: Backache (3.6% ) Respiratory: Nasopharyngitis (12.4% ) Serious Cardiovascular: Disorder of cardiovascular system (3% or less )， Electrocardiogram abnormal Immunologic: Hypersensitivity reaction (3% or less ) Ophthalmic: Angle-closure glaucoma， Worsening (3% or less ) Renal: Urinary retention， Worsening (3% or less ) Respiratory: Bronchospasm (3% or less )， Pneumonia |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                          |

